Forecast & Rating4 analysts currently cover InnoCare Pharma, of which 3 give a positive rating. The average price target is ¥30.72, about 12.0% upside from the current price of ¥27.43. Coverage is limited, so the data is for reference only. Data as of May 4, 2026; this does not constitute investment advice.
May 1, 2026
Price forecast
¥30.7212.00%
Forecast & RatingBuy
4analysts
Strong buy75.00%
Buy0.00%
Hold25.00%
Sell0.00%
Strong sell0.00%
Strong buy
3
Buy
0
Hold
1
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 26, 2026
Forecast met71.5%
Stock price$27.43
Average forecast price$31.0
Highest forecast price$47
Lowest forecast price$20
Average forecast price
$31.0
Highest forecast price
$47
Lowest forecast price
$20
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.